The growing needs of an aging population and a rise in chronic disorders will help the European market for remote patient-monitoring devices to reach $400 million by 2014, according to a Frost & Sullivan report. Restricted reimbursement for the devices in Europe, however, may prove challenging to companies, according to the report.

Full Story:

Related Summaries